Teva is happy to announce the
8th Nordic Migraine Symposium
13-14 November 2026
Scandic Park Helsinki, Finland
2 days where experts meet to discuss and shape migraine management
+20 sessions advancing migraine care from molecular mechanisms to real-world clinical impact
Bridging science and practice to prevent progression and improve outcomes in migraine
Advancing migraine care through shared best practice
Contact
If you have any questions regarding the symposium, please contact your local Teva Medical Affairs representative:
Denmark: Nadeem Mohammad / +45 236 604 04
Sweden: Fredrik Blomstrand / +46 706 689 003
Norway: Ole Henrik Osen / +47 415 450 75
Finland: Anna Hanttu / +358 50 966 2702
On behalf of the Steering Committee and Medical Affairs Teva Nordics
About the Nordic Migraine Symposium
Teva is a global company working in generics and innovative medicine. Teva is committed to bringing medicine, education and innovative solutions to health care professionals and with the ultimate goal of improving patient lives.
Aligned with this commitment, Teva Nordic Medical Affairs has since 2019 arranged an annual scientific symposium within migraine intended to be complementary to other international congresses and with highest clinical and scientific relevance. This series of symposia have top international migraine experts in the steering committee and as speakers. We strive to provide the speakers an opportunity to present their work/research in an environment facilitating interactions and discussions.
Steering committee
Marja-Liisa Sumelahti
Associate Professor at Tampere University, Neurologist at Terveystalo Tampere, Finland
Mattias Linde
Visiting professor of Neurology in the Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, and Consultant Neurologist at the Sahlgrenska University Hospital, Gothenburg, Sweden
Messoud Ashina
Professor of Neurology at Rigshospitalet Glostrup, Denmark.
Anne Christine Poole
General practitioner and headache specialist at Oslo Headache Center AS, Norway.